- Price is above the Trend Line, keeping the weekly tape constructive.
- Activity pressure is positive on the latest completed week.
SURI
JKT
Week ended 07 Aug 2026
Weekly Investor Report
Maja Agung Latexindo Tbk. · Healthcare · Medical Instruments & Supplies
Latest close
72.00 IDR
0.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 0.9% above the Trend Line and sits at 18.4% of its 52-week range. The latest completed week returned 0.0%, after a 10.8% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
39
out of 100
Latest Close
72.00 IDR
7 Aug 2026
1W Return
0.0%
latest completed week
4W Return
10.8%
short-term follow-through
12W Return
-8.9%
quarterly tape
Trend Breadth
32.7%
17 of 52 weeks active
Volume Ratio
0.5x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Next-week expectancy is negative at 38.33% based on similar historical setup states.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
0.0%
Latest completed week; four-week move 10.8%.
Indicator stack
18/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 38.33%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 0.9% above the Trend Line and sits at 18.4% of its 52-week range. The latest completed week returned 0.0%, after a 10.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0812-week average 0.06
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.08Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 10.8% over four weeks, -8.9% over 12 weeks, and -36.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year17
Trend breadth32.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.39Latest activity-pressure read.
Pressure change1537.3%Four-week change in activity pressure.
Leadership-1.07Latest relative-leadership reading.
RS change82.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-52.6%Distance below the 52-week high.
13-week volatility6.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2610 weeks finished lower.
Best week+14.8%Week of 3 Apr.
Worst week-17.5%Week of 6 Mar.
Latest week+0.0%Week of 7 Aug.
Shape of recent returns
Strong gains7
Modest gains7
Flat weeks2
Modest losses4
Sharp losses6
Recent vol6.3%13-week weekly-return volatility.
Base vol7.0%52-week weekly-return volatility.
Up/down split23/25Count of positive and negative weeks in the 52-week window.
Average skew5.2% / -6.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorID Healthcare
4-week rank7 / 38
Group average4.5%
Trend breadth15.8%
Trend15.8%active weekly trend signals
MD44.7%positive activity pressure
RS73.7%positive relative leadership
Four-week leaders
IndustryID Medical Instruments & Supplies
4-week rank2 / 4
Group average3.5%
Trend breadth25.0%
Trend25.0%active weekly trend signals
MD50.0%positive activity pressure
RS75.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape36/100
Trend, activity pressure, participation, and risk combine to a 36/100 tape read.
Indicator analysis30/100Latest 12-week confirmation: trend 0/12, activity pressure 11/12, relative leadership 1/12.
Activity pressure 0.08; No reversal markers Next-Week ExpectancyNegative 38.33%Next-week expectancy is negative with a 38.33% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 72.00 IDR | 0.0% | 71.33 IDR | 127.5 IDR | 0.39 | -1.07 | 26.4M | Off |
| 31 Jul 2026 | 72.00 IDR | 4.3% | 72.10 IDR | 127.9 IDR | 0.25 | 1.04 | 32.5M | Off |
| 24 Jul 2026 | 69.00 IDR | 3.0% | 72.73 IDR | 128.3 IDR | 0.08 | -3.18 | 24.3M | Off |
| 17 Jul 2026 | 67.00 IDR | 3.1% | 73.50 IDR | 128.8 IDR | 0.03 | -6.37 | 34.0M | Off |
| 10 Jul 2026 | 65.00 IDR | 6.6% | 74.53 IDR | 129.2 IDR | 0.02 | -5.99 | 105.2M | Off |
| 3 Jul 2026 | 61.00 IDR | 1.7% | 75.70 IDR | 129.7 IDR | 0.01 | -11.19 | 1.7M | Off |
| 26 Jun 2026 | 60.00 IDR | -1.6% | 77.00 IDR | 130.2 IDR | -0.03 | -13.23 | 2.1M | Off |
| 19 Jun 2026 | 61.00 IDR | 3.4% | 78.33 IDR | 130.8 IDR | 0.00 | -16.11 | 2.1M | Off |
| 12 Jun 2026 | 59.00 IDR | 1.7% | 79.60 IDR | 131.3 IDR | 0.05 | -16.92 | 3.6M | Off |
| 5 Jun 2026 | 58.00 IDR | -15.9% | 80.97 IDR | 131.9 IDR | 0.37 | -12.30 | 3.6M | Off |
| 29 May 2026 | 69.00 IDR | -1.4% | 82.47 IDR | 132.4 IDR | 0.80 | -4.48 | 11.0M | Off |
| 22 May 2026 | 70.00 IDR | -11.4% | 83.50 IDR | 132.9 IDR | 0.91 | -3.13 | 74.1M | Off |
| 15 May 2026 | 79.00 IDR | -6.0% | 84.47 IDR | 133.4 IDR | 0.85 | 0.74 | 321.0M | Off |
| 8 May 2026 | 84.00 IDR | 7.7% | 85.03 IDR | 133.9 IDR | 0.34 | 3.95 | 516.1M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.